A Promising Heart Drug Fails, Challenging a Long-Held Theory of Disease

A Promising Heart Drug Fails, Challenging a Long-Held Theory of Disease(nytimes.com)

4 points by bhouston 6 days ago | 1 comment

bhouston 6 days ago |

TL;DR summary:

The drug cut inflammation markers (IL-6, CRP) as intended but didn't reduce cardiovascular events or deaths versus placebo. This undermines the "inflammation causes atherosclerosis" thesis.

bhouston 6 days ago |

TL;DR summary:

The drug cut inflammation markers (IL-6, CRP) as intended but didn't reduce cardiovascular events or deaths versus placebo. This undermines the "inflammation causes atherosclerosis" thesis.